InvestorsHub Logo
Followers 58
Posts 3961
Boards Moderated 0
Alias Born 04/23/2013

Re: None

Monday, 05/20/2024 4:33:21 PM

Monday, May 20, 2024 4:33:21 PM

Post# of 426487
The moderator brought up Wegovy and the tie-in for weight loss vs cv risk reduction. Maybe Patrick should have answered with the results from REDUCE-IT BMI. REDUCE-IT demonstrated a very robust risk reduction in all levels of BMI. 93% of all REDUCE-IT patients were classified as Overweight or Obese. Wegovy can’t hold a candle to VASCEPA®/VAZKEPA® in CV risk Reduction!

I’m 100% sure the data in REDUCE-IT will show significant BMI, and weight loss comparable to or even better than that expensive Wegovy crap. I’ve contacted Dr. Bhatt about this and I’m waiting for a reply.

Furthermore, the side effects on Ozempic carries a “Black-Box” Warning THAT are serious. So, if you want to lose weight get your lazy ass off the couch and invest in a bike! If you want to save your life, ask your doc for an Rx of VASCEPA®!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News